Medtronic's MiniMed Flex insulin pump receives FDA clearance, boosting diabetes technology exposure.

Medtronic's diabetes business, MiniMed, has received FDA clearance for its MiniMed Flex insulin pump, a next-generation, smartphone-controlled pump that is materially smaller than prior MiniMed devices. MiniMed plans a commercial launch following this clearance, adding a new product to the Medtronic ecosystem. The FDA clearance reinforces Medtronic's exposure to connected diabetes care, a core part of its medical equipment focus.